Advisor Partners’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $395K | Sell |
28,129
-206
| -0.7% | -$2.89K | 0.03% | 554 |
|
|
2022
Q1 | $406K | Buy |
28,335
+12,608
| +80% | +$181K | 0.03% | 578 |
|
|
2021
Q4 | $215K | Sell |
15,727
-11,360
| -42% | -$155K | 0.01% | 798 |
|
|
2021
Q3 | $444K | Buy |
27,087
+761
| +3% | +$12.5K | 0.03% | 517 |
|
|
2021
Q2 | $443K | Buy |
26,326
+211
| +0.8% | +$3.55K | 0.03% | 542 |
|
|
2021
Q1 | $477K | Buy |
26,115
+2,589
| +11% | +$47.3K | 0.03% | 492 |
|
|
2020
Q4 | $428K | Sell |
23,526
-7,879
| -25% | -$143K | 0.03% | 494 |
|
|
2020
Q3 | $560K | Buy |
31,405
+7,708
| +33% | +$137K | 0.05% | 355 |
|
|
2020
Q2 | $425K | Buy |
23,697
+9,678
| +69% | +$174K | 0.04% | 406 |
|
|
2020
Q1 | $212K | Buy |
14,019
+1,224
| +10% | +$18.5K | 0.03% | 534 |
|
|
2019
Q4 | $256K | Buy |
+12,795
| New | +$256K | 0.03% | 538 |
|
|
2019
Q2 | – | Sell |
-11,214
| Closed | -$228K | – | 670 |
|
|
2019
Q1 | $228K | Buy |
+11,214
| New | +$228K | 0.03% | 548 |
|